To learn more about cancer prevention and risk reduction, we talked to Raymond N. DuBois, MD, PhD, FAACR, co-editor in chief of the American Association for Cancer Research (AACR)’s journal Cancer Prevention Research and...
Many of the most common cancers are heralded by premalignant conditions. Treating premalignancy may prove to be the most promising tactic for cancer interception.
Esophageal adenocarcinoma increasingly found in adults under 50, study finds
Study suggests that germline genetics may influence lung cancer risk in this patient population. Native American ancestry was associated with increased mutations in the EGFR gene in lung cancer patients from Latin American countries,...
Steroid used to prevent swelling in the brains of patients with glioblastoma may have “detrimental effect” on treatment with immune checkpoint inhibitors.
Artificial intelligence may help predict response to immunotherapy among patients with metastatic melanoma, study reports.
Disproportionate share of the burden of premature cancer deaths in the United States falls on racial and ethnic minorities and on younger people. More than 4 million potential years of life were lost to...
nce thought sterile, lungs can harbor microbes that may affect lung cancer pathogenesis and prognosis.
A draft recommendation from the U.S. Preventive Services Task Force calls for colorectal cancer screening to start at age 45, rather than 50.
Study results show importance of considering age of the patient in cancer treatment.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More